pharmaceuticals-and-healthcare

Asia-Pacific Neurological Biomarkers Market Report 2018


Published On : Jan 2018

Category : Biomarkers

No. of Pages : 156 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  

This report studies the Neurological Biomarkers Market status and outlook of Asia-Pacific and major countries, from angles of players, regions, product types and end industries; this report analyzes the top players in Asia-Pacific and major countries, and splits the Neurological Biomarkers Market by product type and applications/end industries.


In the last several years, Asia Pacific market of Neurological Biomarkers developed rapidly, with an average growth rate of 21.4%. In 2017, Asia Pacific revenue of Neurological Biomarkers is nearly 360 M USD.


The major players in Asia Pacific Neurological Biomarkers market include
Thermo Fisher
Merck
Bio-Rad Laboratories
Roche
QIAGEN
Athena Diagnostics
Myriad RBM
Cisbio Bioassays
Wuxi APP
BGI
Aepodia
Genewiz
Proteome Sciences


Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Neurological Biomarkers in these regions, from 2013 to 2024 (forecast), covering
Japan
China
India
Korea
Southeast Asia
Australia
RoAP


On the basis of product, the Neurological Biomarkers market is primarily split into
Proteomics
Genomics
Imaging
Bioinformatics
Others


On the basis on the end users/applications, this report covers
Diagnostics
Drug Discovery
Personalized Medicine
Others



 

Drug discovery plays a pivotal role in the advancements of all markets associated with biomarkers. With the bulk of the players in this field pushing for greater strides in research and development, they are also likely to receive better investments and catalytic boosts from both private as well as government entities. Joining principal segments of industry knowledge, precisely filed information, and solid research systems, the outcome is a research report loaded with all the information that is pivotal in fully understanding what could be possible when enhancing one's stature in the Asia pacific neurological biomarkers market report 2018. The market is depicted in all detail, giving clients of this report with the most recent and the most correlated data that they will require to arrange out their next business strategy. The significance of the Asia pacific neurological biomarkers market report 2018 inside the biomarkers industry is as of now a known component. While one might say that the advance rate of the market is expected to change over the coming years, there needs to be a guided arrangement that will help every client handle key market issues. The underlying fragments of the report form the nuts and bolts of the market machine. This includes the arrangements, definitions, and the rating of all key classes that help characterize the market. Once these basics are built up, the report moves into the total examination of the market, which includes dissecting the market on the premise of a few classifications and breaking down each of them exclusively.

Exclusive research philosophies are blended with demonstrated industry standard investigations to gage the regional drivers and openings inside the Asia pacific neurological biomarkers market report 2018. To the regional players, this can be of incredible advantage because of the introduction of various opportunities becoming distinctly noticeable inside their location of operations. Internationally unique players can likewise take full advantage of the territorially isolated examination of the market keeping in mind that their end goal is to reasonably strengthen their area specific developments while extending their business over newer regions. The techniques as of now in execution by the readers of this report can likewise be calibrated to reverberate with the end user inclinations, government policies, and cumulative extent of every key region. As we definitely know the immense assorted qualities that accompany the Asia pacific neurological biomarkers market report 2018, it is vital to recognize these distinctions with respect the purpose to capitalizing on any market circumstance.

The competitive index in the biomarkers industry are large enough to show a seriously aggressive nature from the business sectors, and the Asia pacific neurological biomarkers market report 2018 is no exception to this. Hence, depicting the opposition in the market through the eyes of its leading players can paint the ideal picture for players of all sizes. The readers of this report can, through this competitive analysis, increase their wealth of indispensable data on the player profiles, business systems, qualities, shortcomings, and dangers displayed by the present leaders of the market, and additionally the ones that are demonstrating high development potential. The market is likewise no outsider to prominent mergers and acquisitions, and in addition provincially focused entrance endeavors by players of all sizes, and the report can give a holistic snapshot it all.

List of Tables and Figures

Figure Product Picture of Neurological Biomarkers2
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Comparison by Types (2013-2024)3
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 20174
Figure Genomics Product Picture5
Figure Proteomics Product Picture5
Figure Imaging Product Picture6
Figure Bioinformatics Product Picture6
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Comparison by Applications (2013-2024)7
Figure Asia-Pacific Revenue Market Share of Neurological Biomarkers by Applications in 20178
Figure Drug Discovery Examples8
Figure Diagnostics Examples9
Figure Personalized Medicine Examples10
Table Asia-Pacific Market Neurological Biomarkers Revenue (M USD) Comparison by Regions 2013-202411
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)12
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)13
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)14
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)15
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)16
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)17
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)18
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)19
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Players/Manufacturers (2016-2017)20
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers (2016-2017)20
Figure 2016 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers21
Figure 2017 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers22
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Type (2013-2018)22
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Type (2013-2018)23
Figure Revenue Market Share of Neurological Biomarkers by Type (2013-2018)23
Figure Asia-Pacific Neurological Biomarkers Revenue Growth Rate by Type in 201724
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Regions (2013-2018)24
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions (2013-2018)25
Figure Revenue Market Share of Neurological Biomarkers by Regions (2013-2018)25
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions in 201726
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Application (2013-2018)26
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)27
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)27
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application in 201728
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)29
Table China Neurological Biomarkers Revenue (M USD) by Type (2013-2018)29
Table China Neurological Biomarkers Revenue Market Share by Type (2013-2018)30
Figure China Neurological Biomarkers Revenue Market Share by Type in 201730
Table China Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)31
Table China Neurological Biomarkers Revenue Market Share by Applications (2013-2018)31
Figure China Neurological Biomarkers Revenue Market Share by Applications in 201732
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)33
Table Japan Neurological Biomarkers Revenue (M USD) by Type (2013-2018)34
Table Japan Neurological Biomarkers Revenue Market Share by Type (2013-2018)34
Figure Japan Neurological Biomarkers Revenue Market Share by Type in 201735
Table Japan Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)35
Table Japan Neurological Biomarkers Revenue Market Share by Applications (2013-2018)36
Figure Japan Neurological Biomarkers Revenue Market Share by Applications in 201736
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)37
Table Korea Neurological Biomarkers Revenue (M USD) by Type (2013-2018)37
Table Korea Neurological Biomarkers Revenue Market Share by Type (2013-2018)38
Figure Korea Neurological Biomarkers Revenue Market Share by Type in 201738
Table Korea Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)39
Table Korea Neurological Biomarkers Revenue Market Share by Applications (2013-2018)39
Figure Korea Neurological Biomarkers Revenue Market Share by Applications in 201740
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)41
Table India Neurological Biomarkers Revenue (M USD) by Type (2013-2018)41
Table India Neurological Biomarkers Revenue Market Share by Type (2013-2018)42
Figure India Neurological Biomarkers Revenue Market Share by Type in 201742
Table India Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)43
Table India Neurological Biomarkers Revenue Market Share by Applications (2013-2018)43
Figure India Neurological Biomarkers Revenue Market Share by Applications in 201744
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)45
Table Australia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)46
Table Australia Neurological Biomarkers Revenue Market Share by Type (2013-2018)46
Figure Australia Neurological Biomarkers Revenue Market Share by Type in 201747
Table Australia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)47
Table Australia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)48
Figure Australia Neurological Biomarkers Revenue Market Share by Applications in 201748
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)49
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)49
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Type (2013-2018)50
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Type in 201750
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)51
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)51
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Applications in 201752
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)53
Table RoAP Neurological Biomarkers Revenue (M USD) by Type (2013-2018)54
Table RoAP Neurological Biomarkers Revenue Market Share by Type (2013-2018)54
Figure RoAP Neurological Biomarkers Revenue Market Share by Type in 201755
Table RoAP Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)55
Table RoAP Neurological Biomarkers Revenue Market Share by Applications (2013-2018)55
Figure RoAP Neurological Biomarkers Revenue Market Share by Applications in 201756
Table Thermo Fisher Company Profile57
Figure Neurological Biomarkers Product Picture and Specifications of Thermo Fisher59
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Thermo Fisher 2016-201760
Table Merck Company Profile60
Figure Neurological Biomarkers Product Picture and Specifications of Merck61
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck 2016-201761
Table Bio-Rad Laboratories Company Profile62
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bio-Rad Laboratories 2016-201764
Table Roche Company Profile64
Table Neurological Biomarkers Product Picture and Specifications of Roche66
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2016-201766
Table QIAGEN Company Profile67
Table Neurological Biomarkers Product Picture and Specifications of QIAGEN68
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of QIAGEN 2016-201769
Table Athena Diagnostics Company Profile69
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Athena Diagnostics 2016-201771
Table Myriad RBM Company Profile71
Figure Neurological Biomarkers Product Picture and Specifications of Myriad RBM73
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Myriad RBM 2016-201773
Table Cisbio Bioassays Company Profile74
Figure Neurological Biomarkers Product Picture and Specifications of Cisbio Bioassays75
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cisbio Bioassays 2016-201775
Table Wuxi APP Company Profile76
Table Neurological Biomarkers Product Picture and Specifications of Wuxi APP77
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Wuxi APP 2016-201777
Table BGI Company Profile78
Table Neurological Biomarkers Product Picture and Specifications of BGI79
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of BGI 2016-201779
Table Aepodia Company Profile79
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Aepodia 2016-201781
Table Genewiz Company Profile81
Table Neurological Biomarkers Product Picture and Specifications of Genewiz82
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Genewiz 2016-201782
Table Proteome Sciences Company Profile83
Table Neurological Biomarkers Product Picture and Specifications of Proteome Sciences84
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Proteome Sciences 2016-201784
Figure typical phases from research to the market for a drug candidate86
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound87
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound88
Figure Manufacturing Cost Structure of Neurological Biomarkers88
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)89
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)89
Figure Cost of Employing a Factory Worker91
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe92
Figure Monthly Minimum Wages in Asia 201693
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)94
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)94
Table Average Price of Electricity to Ultimate Customers95
Figure Electricity Prices for Household Consumers in 201696
Figure Summary of the Driving Assumptions97
Figure Industrial Electric Rates 2016 (PER KWH)98
Figure Manufacturing Process Analysis of Neurological Biomarkers99
Figure Neurological Biomarkers Industrial Chain Analysis100
Table Major Buyers of Neurological Biomarkers101
Table Distributors/Traders List108
Figure Biomarker Development Pipeline111
Figure Shotgun Proteomics For Biomarker Candidate Discovery113
Figure Spectral Counting113
Figure Targeted Quantitative Analyses of Biomarker Candidates114
Figure Antibody Development for Biomarker Candidates115
Figure Global GDP Growth Rate for 2016117
Figure Japan GDP 2006-2016 (Billion USD)118
Figure Japan CPI Change 2012-2016118
Figure China GDP 2006-2016 (Billion USD)119
Figure China CPI Change 2016-2017119
Figure Korea GDP 2006-2016 (Billion USD)120
Figure Korea CPI Change 2017120
Figure India GDP 2006-2016 (Billion USD)120
Figure India CPI Change 2017121
Figure Australia GDP 2006-2016 (Billion USD)121
Figure Australia CPI Change 2015-2017121
Figure Taiwan GDP 2006-2016 (Billion USD)122
Figure Taiwan CPI Change 2017122
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)123
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Regions (2018-2024)124
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2024)124
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions in 2023125
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)126
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)127
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)128
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)129
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)130
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)131
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)132
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Type (2018-2024)132
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Type (2018-2024)133
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Application (2018-2024)133
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Application (2018-2024)134
Table Research Programs/Design for This Report136
Figure Bottom-up and Top-down Approaches for This Report138
Figure Data Triangulation139
Table Key Data Information from Secondary Sources140
Table Key Data Information from Primary Sources141

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top